Dotzlaw H, Leygue E, Watson P H, Murphy L C
Department of Biochemistry and Molecular Biology, University of Manitoba, Winnipeg, Canada.
J Clin Endocrinol Metab. 1997 Jul;82(7):2371-4. doi: 10.1210/jcem.82.7.4212.
The expression of a recently described novel estrogen receptor, ER-beta, was detected in several human breast tumor biopsy samples and several human breast epithelial cell lines using reverse transcription and polymerase chain reaction (RT-PCR) analysis. Cloning and sequencing of the PCR product from a breast tumor confirmed the identity of the sequence with that of the ER-beta mRNA previously reported in human testis. The expression of ER-beta was not correlated with that of ER-alpha, and both ER-alpha positive and ER-alpha negative cell lines expressed ER-beta mRNA. However, some breast tumors and some cell lines coexpress ER-beta and ER-alpha mRNA. Our data support a possible role for ER-beta in human breast cancer.
利用逆转录聚合酶链反应(RT-PCR)分析,在几份人类乳腺肿瘤活检样本和几个人类乳腺上皮细胞系中检测到一种最近描述的新型雌激素受体ER-β的表达。来自乳腺肿瘤的PCR产物的克隆和测序证实了该序列与先前在人类睾丸中报道的ER-β mRNA序列相同。ER-β的表达与ER-α的表达不相关,ER-α阳性和ER-α阴性细胞系均表达ER-β mRNA。然而,一些乳腺肿瘤和一些细胞系共表达ER-β和ER-α mRNA。我们的数据支持ER-β在人类乳腺癌中可能发挥的作用。